Featured projects

  • Desarrollo de una herramienta de cribado de nuevos fármacos para el tratamiento de la enfermedad hepática crónica a partir de un sistema in vitro hepático organotípico derivado de iPSC

    Principal investigator: Pau Sancho Bru.
    Funder: Instituto de Salud Carlos III (ISCIII) .
    Code: DTS18/00088.
    Duration: 01/01/2019 - 31/12/2020
  • Liver-enriched Transcription Factors as Prognostic Markers and Therapeutic Targets in Alcoholic Hepatitis (LiverTF)

    Principal investigator: Pau Sancho Bru.
    Funder: National Institutes of Health (NIH) .
    Code: 5U01AA026972.
    Duration: 22/09/2018 - 30/06/2020
  • Mecanismos implicados en la deficiente reparación tisular del hígado en enfermedades crónicas hepáticas. Nuevas dianas terapéuticas

    Principal investigator: Pau Sancho Bru.
    Funder: Instituto de Salud Carlos III (ISCIII) .
    Code: PI17/00673.
    Duration: 01/01/2018 - 31/12/2020
  • Role of liver progenitor cells in the progression of alcoholic liver disease

    Principal investigator: Pau Sancho Bru.
    Funder: Institut d`Investigacions Biomèdiques August Pi i Sunyer (Sede); The European Foundation for Alcohol Research (ERAB) .
    Code: INT-ERAB-16 (EA-16-53).
    Duration: 01/01/2017 - 31/12/2018
  • Generacion de un cultivo organotipico hepatico con celulas no-parenquimales derivadas de iPS. Nuevas herramientas celulares para estudios de toxicologia (HepaTox)

    Principal investigator: Pau Sancho Bru.
    Funder: Institut D'investigacions Biomediques August Pi i Sunyer (Idibaps) (Sede); Ministerio de Economia y Competitividad (MINECO) .
    Code: BIO2014-61654-EXP.
    Duration: 01/09/2015 - 31/08/2016
  • Papel de las células progenitoras hepáticas en la hepatitis alcohólica y su potencial como nueva diana terapéutica.

    Principal investigator: Pau Sancho Bru.
    Funder: Institut D'investigacions Biomediques August Pi i Sunyer (Idibaps) (Sede); Instituto de Salud Carlos III (ISCIII) .
    Code: PI14/00320.
    Duration: 01/01/2015 - 31/12/2017
  • Molecular Subtypes for Targeted Therapies in Alcoholic Hepatitis

    Principal investigator: Pau Sancho Bru.
    Funder: Institut D'investigacions Biomediques August Pi i Sunyer (Idibaps) (Sede); National Institutes of Health (NIH) ; Institut d'Investigacions Biomèdiques August Pi i Sunyer (Entidad de origen).
    Code: U01AA021908.
    Duration: 01/06/2013 - 31/05/2018
  • Use of liver progenitor cells and stem cells as a potential novel therapy approach to treat acute on chronic liver failure

    Principal investigator: Pau Sancho Bru.
    Funder: Universitat de Barcelona (Sede); Instituto de Salud Carlos III (ISCIII) .
    Code: CP11/00071.
    Duration: 01/01/2012 - 31/12/2014
  • MIF in progression and treatment of Alcoholic Liver Disease

    Principal investigator: Pau Sancho Bru.
    Funder: Institut D'investigacions Biomediques August Pi i Sunyer (Idibaps) (Sede); National Institutes of Health (NIH) ; Institut d'Investigacions Biomèdiques August Pi i Sunyer (Entidad de origen).
    Code: 1U01AA020821-01A1.
    Duration: 01/01/2012 - 01/01/2017
  • Hepatic Microfluidic Bioreactor (HeMiBio)

    Principal investigator: Pau Sancho Bru.
    Funder: Institut D'investigacions Biomediques August Pi i Sunyer (Idibaps) (Sede); European Comission (EC) ; Institut d'Investigacions Biomèdiques August Pi i Sunyer (Entidad de origen).
    Code: FP7-2010-Alt.Test (266777).
    Duration: 01/01/2011 - 31/12/2015